Microbot Medical Inc
Microbot Medical Inc. is a pre-commercial stage medical technology company with a vision to improve the quality of care for millions of patients and providers globally. The Company has developed the world’s first single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems.
Current Price
$1.85
+0.00%Microbot Medical Inc (MBOT) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Microbot Medical Inc's financial performance and position as a Healthcare company.
Trailing twelve-month (TTM) revenue is $105000.00. Gross profit (TTM) is $2000.00. EBITDA is $-14.17M. Earnings per share (EPS) is $-0.29. The P/E ratio is -8.74. Market capitalization is $124.24M.
Free cash flow (FCF) is $-13.11M. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Microbot Medical Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.
